Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aveanna Healthcare Holdings (AVAH) Total Liabilities (2020 - 2026)

Aveanna Healthcare Holdings (AVAH) has disclosed Total Liabilities for 6 consecutive years, with $1.8 billion as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Total Liabilities changed 0.08% year-over-year to $1.8 billion, compared with a TTM value of $1.8 billion through Sep 2025, changed 0.08%, and an annual FY2024 reading of $1.8 billion, up 2.59% over the prior year.
  • Total Liabilities was $1.8 billion for Q3 2025 at Aveanna Healthcare Holdings, up from $1.8 billion in the prior quarter.
  • Across five years, Total Liabilities topped out at $1.8 billion in Q3 2025 and bottomed at $1.2 billion in Q4 2021.
  • Average Total Liabilities over 5 years is $1.7 billion, with a median of $1.7 billion recorded in 2023.
  • The sharpest move saw Total Liabilities soared 537.3% in 2021, then decreased 0.99% in 2025.
  • Year by year, Total Liabilities stood at $1.2 billion in 2021, then skyrocketed by 43.1% to $1.7 billion in 2022, then rose by 1.43% to $1.7 billion in 2023, then increased by 2.59% to $1.8 billion in 2024, then grew by 0.84% to $1.8 billion in 2025.
  • Business Quant data shows Total Liabilities for AVAH at $1.8 billion in Q3 2025, $1.8 billion in Q2 2025, and $1.8 billion in Q1 2025.